other key events that come to mind:
1. PMS breakthrough designation should the result be 'groundbreaking'
2. Q4 sales update by Acadia in early Feb
3. Pitt Hopkins phase 2 read out in April/May
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial, page-36
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
-0.240(1.55%) |
Mkt cap ! $1.940B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $2.923M | 192.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 33 | $15.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.24 | 1268 | 7 |
View Market Depth
| Last trade - 12.01pm 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |